简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-08-30 13:34 US FDA Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab
2022-08-30 10:07 ABEC Announces $11 Million Investment in a New Manufacturing Facility in North Carolina
2022-08-29 18:14 Mary Kay Announces Outcomes of SDG Pilot Village Project in China (2017-2021) With Release of Impact Report and Video
2022-08-29 17:10 SunLike Lighting, With Proven Effectiveness of Myopia Improvement, to Light up a Major English-Speaking Kindergarten in Korea
2022-08-29 17:02 The Polypill Reduces Cardiovascular Mortality by 33% in Patients Treated After Myocardial Infarction
2022-08-29 14:13 PCI Pharma Services Opens New England Center of Excellence to Bring Global Clinical Supply Capabilities to New England
2022-08-29 11:26 SaNOtize Announces $24 Million in Series B Funding to Advance Its Nitric Oxide-Based Therapeutics, Including Nasal Spray for the Treatment and Prevention of COVID-19
2022-08-29 11:21 Covetrus Names Margie B. Pritchard General Counsel
2022-08-25 17:14 Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved in Indonesia for Use Regardless of Prior Dengue Exposure
2022-08-25 14:21 Galderma Delivers Strong H1 2022 Results and Continued Innovation Across Its Leading Dermatology Portfolio
2022-08-25 14:17 Biocytogen Expands Partnership with Merck
2022-08-25 09:51 Frazier Life Sciences Adds Senior R&D Leader to Team
2022-08-24 18:25 Morinaga Milk Obtains FDA GRAS Notification for its Probiotic
2022-08-24 18:16 AdvanCell Closes A$18M Series B Funding Led by Morningside
2022-08-24 10:04 Medisca Unveils New Brand Identity and Corporate Positioning as Partners in Wellness
2022-08-23 14:27 Miracor Medical Announces FDA IDE Approval For PiCSO® Pivotal Study
2022-08-23 13:31 Solasia Announces Launch of Darvias® in Japan
2022-08-23 09:10 CSL Vifor and Travere Therapeutics announce EMA has accepted for review the Conditional Marketing Authorization application for sparsentan for the treatment of IgA Nephropathy
2022-08-22 14:25 VFMCRP announces U.S. Court upholds validity of Velphoro® patent
2022-08-22 09:54 Dermaliq Therapeutics announces first patient dosed in Phase 1b/2 trial evaluating DLQ02 for treatment of plaque psoriasis

Business Wire Weibo

Press Releases

Latest Releases